Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Achilles Therapeutics plc from 31 Dec 2021 to 30 Jun 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: Achilles Therapeutics plc quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Dec 2021 to 30 Jun 2024.
Achilles Therapeutics plc Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Jun 2024 was $197,000, a 61% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$197,000	-$309,000	-61%	30 Jun 2024	6-K	14 Aug 2024	2024	Q2
Q4 2023	$201,000	-$311,000	-61%	31 Dec 2023	20-F	04 Apr 2024	2023	FY
Q2 2023	$506,000			30 Jun 2023	6-K	04 Aug 2023
Q4 2022	$512,000	-$386,000	-43%	31 Dec 2022	20-F	07 Mar 2023	2022	FY
Q4 2021	$898,000			31 Dec 2021	20-F	01 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.